BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30182212)

  • 1. Inhibiting 6-phosphogluconate dehydrogenase enhances chemotherapy efficacy in cervical cancer via AMPK-independent inhibition of RhoA and Rac1.
    Guo H; Xiang Z; Zhang Y; Sun D
    Clin Transl Oncol; 2019 Apr; 21(4):404-411. PubMed ID: 30182212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibiting 6-phosphogluconate dehydrogenase selectively targets breast cancer through AMPK activation.
    Yang X; Peng X; Huang J
    Clin Transl Oncol; 2018 Sep; 20(9):1145-1152. PubMed ID: 29340974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 6PGD inhibition sensitizes hepatocellular carcinoma to chemotherapy via AMPK activation and metabolic reprogramming.
    Chen H; Wu D; Bao L; Yin T; Lei D; Yu J; Tong X
    Biomed Pharmacother; 2019 Mar; 111():1353-1358. PubMed ID: 30841449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 6PGD Upregulation is Associated with Chemo- and Immuno-Resistance of Renal Cell Carcinoma via AMPK Signaling-Dependent NADPH-Mediated Metabolic Reprograming.
    Cao J; Sun X; Zhang X; Chen D
    Am J Med Sci; 2020 Sep; 360(3):279-286. PubMed ID: 32829780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
    Lin R; Elf S; Shan C; Kang HB; Ji Q; Zhou L; Hitosugi T; Zhang L; Zhang S; Seo JH; Xie J; Tucker M; Gu TL; Sudderth J; Jiang L; Mitsche M; DeBerardinis RJ; Wu S; Li Y; Mao H; Chen PR; Wang D; Chen GZ; Hurwitz SJ; Lonial S; Arellano ML; Khoury HJ; Khuri FR; Lee BH; Lei Q; Brat DJ; Ye K; Boggon TJ; He C; Kang S; Fan J; Chen J
    Nat Cell Biol; 2015 Nov; 17(11):1484-96. PubMed ID: 26479318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting 6-phosphogluconate dehydrogenase in the oxidative PPP sensitizes leukemia cells to antimalarial agent dihydroartemisinin.
    Elf S; Lin R; Xia S; Pan Y; Shan C; Wu S; Lonial S; Gaddh M; Arellano ML; Khoury HJ; Khuri FR; Lee BH; Boggon TJ; Fan J; Chen J
    Oncogene; 2017 Jan; 36(2):254-262. PubMed ID: 27270429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 6-Phosphogluconate dehydrogenase regulates tumor cell migration in vitro by regulating receptor tyrosine kinase c-Met.
    Chan B; VanderLaan PA; Sukhatme VP
    Biochem Biophys Res Commun; 2013 Sep; 439(2):247-51. PubMed ID: 23973484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphine Stimulates Migration and Growth and Alleviates the Effects of Chemo Drugs via AMPK-Dependent Induction of Epithelial-Mesenchymal Transition in Esophageal Carcinoma Cells.
    Zhang J; Yao N; Tian S
    Biol Pharm Bull; 2020; 43(5):774-781. PubMed ID: 32378556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A feedback loop between the androgen receptor and 6-phosphogluoconate dehydrogenase (6PGD) drives prostate cancer growth.
    Gillis JL; Hinneh JA; Ryan NK; Irani S; Moldovan M; Quek LE; Shrestha RK; Hanson AR; Xie J; Hoy AJ; Holst J; Centenera MM; Mills IG; Lynn DJ; Selth LA; Butler LM
    Elife; 2021 Aug; 10():. PubMed ID: 34382934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YTH domain family 2 promotes lung cancer cell growth by facilitating 6-phosphogluconate dehydrogenase mRNA translation.
    Sheng H; Li Z; Su S; Sun W; Zhang X; Li L; Li J; Liu S; Lu B; Zhang S; Shan C
    Carcinogenesis; 2020 Jul; 41(5):541-550. PubMed ID: 31504235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 6-Phosphogluconate dehydrogenase fuels multiple aspects of cancer cells: From cancer initiation to metastasis and chemoresistance.
    Sarfraz I; Rasul A; Hussain G; Shah MA; Zahoor AF; Asrar M; Selamoglu Z; Ji XY; Adem Ş; Sarker SD
    Biofactors; 2020 Jul; 46(4):550-562. PubMed ID: 32039535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycolytic cancer cells lacking 6-phosphogluconate dehydrogenase metabolize glucose to induce senescence.
    Sukhatme VP; Chan B
    FEBS Lett; 2012 Jul; 586(16):2389-95. PubMed ID: 22677172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibiting 6-phosphogluconate dehydrogenase reverses doxorubicin resistance in anaplastic thyroid cancer via inhibiting NADPH-dependent metabolic reprogramming.
    Ma L; Cheng Q
    Biochem Biophys Res Commun; 2018 Apr; 498(4):912-917. PubMed ID: 29534964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosine phosphorylation activates 6-phosphogluconate dehydrogenase and promotes tumor growth and radiation resistance.
    Liu R; Li W; Tao B; Wang X; Yang Z; Zhang Y; Wang C; Liu R; Gao H; Liang J; Yang W
    Nat Commun; 2019 Mar; 10(1):991. PubMed ID: 30824700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of 6-Phosphogluconate Dehydrogenase Reverses Epirubicin Resistance Through Metabolic Reprograming in Triple-Negative Breast Cancer Cells.
    Xu J; Ren G; Cheng Q
    Technol Cancer Res Treat; 2023; 22():15330338231190737. PubMed ID: 37559469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical Role of 6-Phosphogluconate Dehydrogenase in TAp73-Mediated Cancer Cell Proliferation.
    Qiao R; Wei M; Chen H; Zhang X; Zhang J; Gao L; Ma H; Wang Y; Li L
    Mol Cancer Res; 2023 Aug; 21(8):825-835. PubMed ID: 37071129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simvastatin enhances chemotherapy in cervical cancer via inhibition of multiple prenylation-dependent GTPases-regulated pathways.
    Pan Q; Xu J; Ma L
    Fundam Clin Pharmacol; 2020 Feb; 34(1):32-40. PubMed ID: 31058344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinically relevant concentration of sevoflurane suppresses cervical cancer growth and migration through targeting multiple oncogenic pathways.
    Ding J; Zhang L; Zeng S; Feng T
    Biochem Biophys Res Commun; 2019 Jul; 514(4):1179-1184. PubMed ID: 31103261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simvastatin-Induced Apoptosis in Osteosarcoma Cells: A Key Role of RhoA-AMPK/p38 MAPK Signaling in Antitumor Activity.
    Kamel WA; Sugihara E; Nobusue H; Yamaguchi-Iwai S; Onishi N; Maki K; Fukuchi Y; Matsuo K; Muto A; Saya H; Shimizu T
    Mol Cancer Ther; 2017 Jan; 16(1):182-192. PubMed ID: 27799356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoflurane activates AMP-activated protein kinase to inhibit proliferation, and promote apoptosis and autophagy in cervical carcinoma both
    Wei H; Sun T; Liu J; Wang X; Zhao G; Shi J; Chen Y
    J Recept Signal Transduct Res; 2021 Dec; 41(6):538-545. PubMed ID: 33043765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.